Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel treatment options in the severe beta-globin disorders.

× No keyword cloud information.

7 in total

1. Quantitative analysis of globin gene induction in single human erythroleukemic cells.

Authors: R D Smith; J D Malley; A N Schechter
Journal: Nucleic Acids Res Date: 2000-12-15 Impact factor: 16.971

2. Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.

Authors: A Olujohungbe; K I Cinkotai; A Yardumian
Journal: BMJ Date: 1998-06-06

3. Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.

Authors: Ilaria Lampronti; Nicoletta Bianchi; Cristina Zuccato; Francesco Dall'Acqua; Daniela Vedaldi; Giampietro Viola; Rocco Potenza; Francesco Chiavilli; Giulia Breveglieri; Monica Borgatti; Alessia Finotti; Giordana Feriotto; Francesca Salvatori; Roberto Gambari
Journal: Int J Hematol Date: 2009-09-25 Impact factor: 2.490

4. CTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood.

Authors: Yan-Ni Ma; Xin Zhang; Hai-Chuan Yu; Jun-Wu Zhang
Journal: BMC Cell Biol Date: 2010-10-09 Impact factor: 4.241

5. Involvement of phosphatases in proliferation, maturation, and hemoglobinization of developing erythroid cells.

Authors: Eitan Fibach
Journal: J Signal Transduct Date: 2011-07-14

6. Eos negatively regulates human γ-globin gene transcription during erythroid differentiation.

Authors: Hai-Chuan Yu; Hua-Lu Zhao; Zhi-Kui Wu; Jun-Wu Zhang
Journal: PLoS One Date: 2011-07-28 Impact factor: 3.240

7. Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors: Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal: Evid Based Complement Alternat Med Date: 2007-12-11 Impact factor: 2.629

7 in total